Publications by authors named "Amber A Eikholt"

Introduction: Asthma is a common disease with a global burden of 358 million patients. Despite improvements in pharmacological and non-pharmacological treatments, many patients still do not achieve complete asthma control. Therefore, innovative pharmacotherapy is important.

View Article and Find Full Text PDF

Introduction: Asthma attacks are a leading cause of morbidity and mortality but are preventable in most if detected and treated promptly. However, the changes that occur physiologically and behaviourally in the days and weeks preceding an attack are not always recognised, highlighting a potential role for technology. The aim of this study 'DIGIPREDICT' is to identify early digital markers of asthma attacks using sensors embedded in smart devices including watches and inhalers, and leverage health and environmental datasets and artificial intelligence, to develop a risk prediction model to provide an early, personalised warning of asthma attacks.

View Article and Find Full Text PDF
Article Synopsis
  • Poor adherence to inhaled medication is linked to negative health outcomes, prompting a study on the feasibility of smart spacers to improve treatment in adults with asthma.
  • The study involved a two-month randomized controlled trial comparing smart spacer-based education with usual care, showing that it significantly reduced inhalation errors.
  • Although the immediate effects on medication adherence and clinical results were mixed, the trial indicated that using smart spacers for asthma education is feasible and warrants further research.
View Article and Find Full Text PDF

Synopsis of recent research by authors named "Amber A Eikholt"

  • - Amber A Eikholt's recent research primarily focuses on innovative approaches to asthma management, such as the development of new inhaled pharmacotherapies and technology-driven solutions for early detection and treatment of asthma attacks.
  • - Notable studies include "DIGIPREDICT," which aims to utilize digital markers and artificial intelligence to predict asthma attacks by monitoring physiological and behavioral changes, enhancing preventive care.
  • - Additionally, the OUTERSPACE trial investigates the use of a digital smart spacer for personalized inhaler education, addressing the critical issue of medication adherence in asthma patients while evaluating the feasibility of smart technology in clinical practice.